Birchview Capital’s IDEAYA Biosciences IDYA Stock Holding History

Birchview Capital’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,860	Closed	-$562K	–	76
2026 Q1	$562K	Buy	+16,860	New	+$566K	0.32%	52

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Birchview Capital's IDYA Position: Q2 2026 in Review

Birchview Capital sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 16,860 shares — an estimated $562K sold.

Birchview Capital first reported a position in IDYA in Q1 2026 and held it in 1 quarter. The position peaked at $562K in Q1 2026. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Birchview Capital reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
Birchview Capital sold 16,860 IDEAYA Biosciences shares in Q2 2026, an estimated $562K.
Birchview Capital first reported a position in IDEAYA Biosciences in Q1 2026 and held it in 1 quarter.
Birchview Capital's IDEAYA Biosciences position peaked at $562K in Q1 2026.
284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.